ESPBs vs TAPs for Satisfactory Analgesia Following DIEP Surgery
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Oct 13, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods to manage pain after a specific type of breast surgery called DIEP flap surgery, which is often performed on women with breast cancer. The researchers want to find out if a newer pain relief technique called Erector Spinae Plane blocks (ESPBs) is just as effective as the more commonly used Transversus Abdominis Plane blocks (TAPs) in controlling pain after surgery. Both methods involve using local anesthetics to numb the area and reduce pain.
To be eligible for this trial, participants must be adult women with breast cancer who are scheduled for DIEP flap surgery and have certain health conditions (classified as ASA 1-3, which relates to their overall physical status). They should not be using chronic opioids or have any conditions that would prevent them from receiving local anesthesia. If they join the study, participants can expect to receive one of the two pain management techniques before their surgery and will be monitored for pain control afterward. This trial is currently recruiting participants who meet the criteria and are looking for effective ways to manage post-surgery pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult women with breast cancer, ASA 1-3, undergoing DIEP flap surgery
- Exclusion Criteria:
- • Chronic opioid use contraindications to local anesthetics or regional analgesia Inability to communicate intensity of pain on a numeric analog scale
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported